ESMO designated centres of integrated oncology and palliative care (ESMO DCs) : education, research and programme development survey

Article indépendant

KREYE, G. | LUNDEBY, T. | LATINO, N. | GALOTTI, M. | KAASA, S.

BACKGROUND: The European Society for Medical Oncology (ESMO) Designated Centres (DCs) of Integrated Oncology and Palliative Care is an incentive programme established in 2003 aiming to improve the integration of oncology and palliative care services provided by oncologists and oncology centres worldwide. Currently, the ESMO DCs programme has over 250 centres accredited from 54 countries worldwide, in all six world regions. MATERIALS AND METHODS: To evaluate how ESMO can support centres to improve programme development, education and research and vice versa what each single centre can do to improve in these areas, we developed a survey which was shared with all active centres. Two hundred and seven ESMO DCs representing 44 countries were invited to participate. We used content analysis to identify response categories using a stepwise approach. After reviewing and coding all responses to each question separately, they were placed into categories, counted and labelled. RESULTS: Of the 207 centres that were invited to participate, 146 centres started the survey, representing 43 countries. Five overarching topics were identified. They included (i) joint events and educational activities; (ii) sharing of materials and defining common standards; (iii) sharing of experiences, scientific knowledge and expertise; (iv) research collaboration; and (v) ESMO support. Respondents were willing to support the ESMO DC community group in all topics and were also asking ESMO to support their centres in these issues in the future. CONCLUSION: The study showed that the ESMO DCs are willing to provide support to improve education, research and programme development. They are also eager to contribute and collaborate amongst each other, but also request ESMO to offer advice and help to improve these issues in the DCs. In the future, facilitation of joint research projects and development of arenas to share experiences, educational and programme developments, and other resources are to be explored and could be offered to the DCs worldwide.

http://dx.doi.org/10.1016/j.esmoop.2022.100622

Voir la revue «ESMO open, 7»

Autres numéros de la revue «ESMO open»

Consulter en ligne

Suggestions

Du même auteur

ESMO designated centres of integrated oncolog...

Article indépendant | KREYE, G. | ESMO open | n°6 | vol.7

BACKGROUND: The European Society for Medical Oncology (ESMO) Designated Centres (DCs) of Integrated Oncology and Palliative Care is an incentive programme established in 2003 aiming to improve the integration of oncology and palli...

Practical cancer nutrition, from guidelines t...

Article indépendant | HUSTAD, K. S. | ESMO open | n°4 | vol.10

BACKGROUND: Malnutrition affects 20%-70% of cancer patients, depending on tumour type, disease stage, and clinical setting. While nutritional care is essential for improving patients' quality of life and clinical outcomes, it is n...

The "critical mass" survey of palliative care...

Article indépendant | HUI, David | Annals of Oncology | n°9 | vol.28

Background: The ESMO Designated Centres (ESMO-DCs) of Integrated Oncology and Palliative Care (PC) Incentive Programme has grown steadily. We aimed to characterise the level of PC clinical services, education and research at ESMO-...

De la même série

Globalization of clinical trials in oncology ...

Article indépendant | IZARN, F. | ESMO open | n°1 | vol.10

BACKGROUND: Over the past two decades, the globalization of oncology clinical trials has expanded, yet significant disparities persist across countries. This study aimed to evaluate these geographical inequalities, the evolution o...

A taxonomy of the factors contributing to the...

Article indépendant | CHERNY, N. I. | ESMO open | n°1 | vol.10

Many patients with cancer approaching the end of life (EOL) continue to receive treatments that are unlikely to provide meaningful clinical benefit, potentially causing more harm than good. This is called overtreatment at the EOL....

Health networking on cancer in the European U...

Article indépendant | CASALI, P. G. | ESMO open | n°2 | vol.10

Health networking is in principle a formidable instrument to address many challenges posed by cancer, one of the two most common and most lethal non-communicable chronic diseases. The European Union (EU)'s Beating Cancer Plan fore...

Quality-of-care indicators for oncology manag...

Article indépendant | KANESVARAN, R. | ESMO open | n°3 | vol.10

Cancer is a major cause of morbidity and mortality, with variable outcomes seen in the Asia-Pacific region due to substantial differences in cancer care and management. Quality indicators are evidence-based, standardized measures ...

Practical cancer nutrition, from guidelines t...

Article indépendant | HUSTAD, K. S. | ESMO open | n°4 | vol.10

BACKGROUND: Malnutrition affects 20%-70% of cancer patients, depending on tumour type, disease stage, and clinical setting. While nutritional care is essential for improving patients' quality of life and clinical outcomes, it is n...

Chargement des enrichissements...